Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments
暂无分享,去创建一个
Jin Liu | Ravi Radhakrishnan | Blaine Zern | Vladimir R Muzykantov | V. Muzykantov | R. Radhakrishnan | D. Eckmann | P. Ayyaswamy | Blaine Zern | Jin Liu | David M Eckmann | Gregory E R Weller | Portonovo S Ayyaswamy | G. Weller
[1] E. Verrier. The vascular endothelium: friend or foe? , 1993, The Annals of thoracic surgery.
[2] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] Molly S. Shoichet,et al. Tunable immunonanoparticle binding to cancer cells: thermodynamic analysis of targeted drug delivery vehicles , 2009 .
[4] Phapanin Charoenphol,et al. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. , 2010, Biomaterials.
[5] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[6] Dietmar W. Siemann,et al. Vascular targeted therapies in oncology , 2008, Cell and Tissue Research.
[7] S. Mitragotri,et al. Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.
[8] M. Davies,et al. The vascular endothelium. A new horizon. , 1993, Annals of surgery.
[9] S. Radford,et al. Nucleation of protein fibrillation by nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[10] Stephen C. Cowin,et al. Mechanotransduction and flow across the endothelial glycocalyx , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] Michael L. Smith,et al. Estimation of viscosity profiles using velocimetry data from parallel flows of linearly viscous fluids: application to microvascular haemodynamics , 2004, Journal of Fluid Mechanics.
[12] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] Samir Mitragotri,et al. Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.
[14] George M. Whitesides,et al. Designing a polyvalent inhibitor of anthrax toxin , 2001, Nature Biotechnology.
[15] Daniel A Hammer,et al. Quantifying nanoparticle adhesion mediated by specific molecular interactions. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[16] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[17] R. Kane,et al. Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins , 2006, Nature Biotechnology.
[18] David S. Long,et al. Near-Wall μ-PIV Reveals a Hydrodynamically Relevant Endothelial Surface Layer in Venules In Vivo , 2003 .
[19] S. Santra,et al. Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. , 2009, Journal of the American Chemical Society.
[20] B. Roux. The calculation of the potential of mean force using computer simulations , 1995 .
[21] Kwang-Hwi Cho,et al. BIOPHYSICS AND COMPUTATIONAL BIOLOGY , 2009 .
[22] V. Moy,et al. Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. , 2002, Biophysical journal.
[23] Silvia Muro,et al. Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1 , 2006, Journal of Pharmacology and Experimental Therapeutics.
[24] Alison Thomas. A new horizon , 2001 .
[25] Berend Smit,et al. Understanding molecular simulation: from algorithms to applications , 1996 .
[26] R. Kane,et al. Polyvalent inhibitors of anthrax toxin that target host receptors , 2006, Proceedings of the National Academy of Sciences.
[27] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[28] A. Mulivor,et al. Role of glycocalyx in leukocyte-endothelial cell adhesion. , 2002, American journal of physiology. Heart and circulatory physiology.
[29] Jens Carlsson,et al. Absolute and relative entropies from computer simulation with applications to ligand binding. , 2005, The journal of physical chemistry. B.
[30] B. Roux,et al. Calculation of absolute protein-ligand binding free energy from computer simulations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Evans,et al. Dynamic strength of molecular adhesion bonds. , 1997, Biophysical journal.
[32] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[33] A. Shah. Vascular endothelium. , 1992, British journal of hospital medicine.
[34] R. Radhakrishnan,et al. The Role of Glycocalyx in Nanocarrier-Cell Adhesion Investigated Using a Thermodynamic Model and Monte Carlo Simulations. , 2007, The journal of physical chemistry. C, Nanomaterials and interfaces.
[35] O. McCarty,et al. Single Molecule Characterization of P-selectin/Ligand Binding* 210 , 2003, The Journal of Biological Chemistry.
[36] P Bongrand,et al. Cell adhesion. Competition between nonspecific repulsion and specific bonding. , 1984, Biophysical journal.
[37] David Vance,et al. The design of polyvalent scaffolds for targeted delivery. , 2009, Advanced drug delivery reviews.
[38] Ali Khademhosseini,et al. Nanobiotechnology drug deliery and tissue engineering drug delivery and tissue engineering , 2006 .
[39] Silvia Muro,et al. Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. , 2009, Biorheology.